Dasiglucagon
Zegalogue (dasiglucagon) is an unknown pharmaceutical. Dasiglucagon was first approved as Zegalogue on 2021-03-22. It is used to treat hypoglycemia in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| nutritional and metabolic diseases | D009750 |
Trade Name
FDA
EMA
Zegalogue
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Dasiglucagon hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ZEGALOGUE | Zealand Pharma | N-214231 RX | 2021-03-22 | 1 products, RLD, RS |
| ZEGALOGUE (AUTOINJECTOR) | Zealand Pharma | N-214231 RX | 2021-03-22 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| zegalogue | New Drug Application | 2023-10-04 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| hypoglycemia | HP_0001943 | D007003 | E16.2 |
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
DASIGLUCAGON HYDROCHLORIDE, ZEGALOGUE, ZEALAND PHARMA | |||
| 2026-03-22 | NCE | ||
DASIGLUCAGON HYDROCHLORIDE, ZEGALOGUE (AUTOINJECTOR), ZEALAND PHARMA | |||
| 2026-03-22 | NCE | ||
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Dasiglucagon Hydrochloride, Zegalogue, Zealand Pharma | |||
| 10442847 | 2035-02-03 | DS, DP | |
ATC Codes
No data
HCPCS
No data
Clinical
No data
Drug
General
| Drug common name | Dasiglucagon |
| INN | dasiglucagon |
| Description | Dasiglucagon, sold under the brand name Zegalogue, is a medication used to treat severe hypoglycemia in people with diabetes.
|
| Classification | Small molecule |
| Drug class | synthetic glucagon analogs |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 1544300-84-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4297741 |
| ChEBI ID | — |
| PubChem CID | 126961379 |
| DrugBank | DB15226 |
| UNII ID | AD4J2O47FQ (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use